nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A1—Clonidine—glaucoma	0.136	0.442	CbGbCtD
Riluzole—CYP1A2—Betaxolol—glaucoma	0.111	0.361	CbGbCtD
Riluzole—CYP1A2—Clonidine—glaucoma	0.0609	0.198	CbGbCtD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—glaucoma	0.00311	0.0488	CbGpPWpGaD
Riluzole—SLC7A11—Basigin interactions—MMP1—glaucoma	0.00208	0.0326	CbGpPWpGaD
Riluzole—SLC7A11—Basigin interactions—CAV1—glaucoma	0.00199	0.0313	CbGpPWpGaD
Riluzole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00187	0.0293	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00183	0.0288	CbGpPWpGaD
Riluzole—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00173	0.0272	CbGpPWpGaD
Riluzole—CYP1A1—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.0017	0.0267	CbGpPWpGaD
Riluzole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.0017	0.0267	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—SLC6A13—glaucoma	0.00147	0.0231	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00139	0.0218	CbGpPWpGaD
Riluzole—CYP1A1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00127	0.0199	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—TXN—glaucoma	0.00121	0.0189	CbGpPWpGaD
Riluzole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00119	0.0187	CbGpPWpGaD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—PAX6—glaucoma	0.00119	0.0186	CbGpPWpGaD
Riluzole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00108	0.017	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—SLC6A1—glaucoma	0.00108	0.0169	CbGpPWpGaD
Riluzole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00106	0.0166	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—PEX19—glaucoma	0.00104	0.0164	CbGpPWpGaD
Riluzole—CYP1A1—Estrogen metabolism—CYP1B1—glaucoma	0.000975	0.0153	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000926	0.0145	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—TGFB2—glaucoma	0.000877	0.0138	CbGpPWpGaD
Riluzole—CYP1A1—Tamoxifen metabolism—CYP1B1—glaucoma	0.000862	0.0135	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000807	0.0127	CbGpPWpGaD
Riluzole—CYP1A1—Estrogen metabolism—GSTM1—glaucoma	0.00078	0.0122	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000705	0.0111	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—MMP1—glaucoma	0.000691	0.0109	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000678	0.0106	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000666	0.0105	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—CAV1—glaucoma	0.000663	0.0104	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000657	0.0103	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—FN1—glaucoma	0.000631	0.00991	CbGpPWpGaD
Riluzole—ABCG2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000627	0.00984	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000622	0.00976	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—GSTM1—glaucoma	0.000596	0.00936	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000578	0.00907	CbGpPWpGaD
Riluzole—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.00055	0.00863	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000539	0.00846	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000497	0.00781	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000471	0.00739	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00047	0.00738	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00046	0.00723	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00046	0.00723	CbGpPWpGaD
Riluzole—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.00046	0.00723	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.000438	0.00688	CbGpPWpGaD
Riluzole—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000431	0.00676	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—NCK2—glaucoma	0.00043	0.00676	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000425	0.00667	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000412	0.00647	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000378	0.00594	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000374	0.00587	CbGpPWpGaD
Riluzole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000372	0.00585	CbGpPWpGaD
Riluzole—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000367	0.00577	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000351	0.00551	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000344	0.00541	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000343	0.00539	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000337	0.00529	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TGFB2—glaucoma	0.000324	0.00509	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000311	0.00489	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00031	0.00487	CbGpPWpGaD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000308	0.00483	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NCK2—glaucoma	0.000307	0.00482	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000302	0.00474	CbGpPWpGaD
Riluzole—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000294	0.00461	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000294	0.00461	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000294	0.00461	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000279	0.00439	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000276	0.00433	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000275	0.00431	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000255	0.00401	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Dorzolamide—glaucoma	0.000247	0.000393	CcSEcCtD
Riluzole—Alopecia—Betaxolol—glaucoma	0.000246	0.000392	CcSEcCtD
Riluzole—Palpitations—Clonidine—glaucoma	0.000246	0.000392	CcSEcCtD
Riluzole—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000246	0.000392	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—SOD1—glaucoma	0.000246	0.00386	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Travoprost—glaucoma	0.000246	0.000391	CcSEcCtD
Riluzole—Loss of consciousness—Clonidine—glaucoma	0.000245	0.00039	CcSEcCtD
Riluzole—Feeling abnormal—Brinzolamide—glaucoma	0.000244	0.000389	CcSEcCtD
Riluzole—Mental disorder—Betaxolol—glaucoma	0.000244	0.000389	CcSEcCtD
Riluzole—Constipation—Pilocarpine—glaucoma	0.000244	0.000388	CcSEcCtD
Riluzole—Pain—Pilocarpine—glaucoma	0.000244	0.000388	CcSEcCtD
Riluzole—Cough—Clonidine—glaucoma	0.000243	0.000387	CcSEcCtD
Riluzole—Sweating—Timolol—glaucoma	0.000243	0.000387	CcSEcCtD
Riluzole—Dizziness—Apraclonidine—glaucoma	0.000243	0.000387	CcSEcCtD
Riluzole—Malnutrition—Betaxolol—glaucoma	0.000243	0.000387	CcSEcCtD
Riluzole—Urticaria—Dorzolamide—glaucoma	0.00024	0.000381	CcSEcCtD
Riluzole—Epistaxis—Timolol—glaucoma	0.000239	0.000381	CcSEcCtD
Riluzole—Body temperature increased—Dorzolamide—glaucoma	0.000238	0.00038	CcSEcCtD
Riluzole—Abdominal pain—Dorzolamide—glaucoma	0.000238	0.00038	CcSEcCtD
Riluzole—Tension—Betaxolol—glaucoma	0.000238	0.000379	CcSEcCtD
Riluzole—Sinusitis—Timolol—glaucoma	0.000238	0.000379	CcSEcCtD
Riluzole—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	0.000238	0.00374	CbGpPWpGaD
Riluzole—Dysgeusia—Betaxolol—glaucoma	0.000238	0.000379	CcSEcCtD
Riluzole—Chest pain—Clonidine—glaucoma	0.000237	0.000378	CcSEcCtD
Riluzole—Arthralgia—Clonidine—glaucoma	0.000237	0.000378	CcSEcCtD
Riluzole—Abdominal pain—Travoprost—glaucoma	0.000237	0.000378	CcSEcCtD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000237	0.00373	CbGpPWpGaD
Riluzole—Agranulocytosis—Timolol—glaucoma	0.000237	0.000377	CcSEcCtD
Riluzole—Anxiety—Clonidine—glaucoma	0.000237	0.000377	CcSEcCtD
Riluzole—Asthenia—Acetazolamide—glaucoma	0.000236	0.000376	CcSEcCtD
Riluzole—Dizziness—Bimatoprost—glaucoma	0.000236	0.000376	CcSEcCtD
Riluzole—Nervousness—Betaxolol—glaucoma	0.000236	0.000375	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000236	0.000375	CcSEcCtD
Riluzole—Urticaria—Brinzolamide—glaucoma	0.000236	0.000375	CcSEcCtD
Riluzole—Feeling abnormal—Pilocarpine—glaucoma	0.000235	0.000374	CcSEcCtD
Riluzole—Discomfort—Clonidine—glaucoma	0.000235	0.000373	CcSEcCtD
Riluzole—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000234	0.00368	CbGpPWpGaD
Riluzole—Vomiting—Apraclonidine—glaucoma	0.000234	0.000372	CcSEcCtD
Riluzole—Muscle spasms—Betaxolol—glaucoma	0.000233	0.000372	CcSEcCtD
Riluzole—Gastrointestinal pain—Pilocarpine—glaucoma	0.000233	0.000371	CcSEcCtD
Riluzole—Hypersensitivity—Brimonidine—glaucoma	0.000233	0.00037	CcSEcCtD
Riluzole—Dry mouth—Clonidine—glaucoma	0.000232	0.00037	CcSEcCtD
Riluzole—Bradycardia—Timolol—glaucoma	0.000232	0.000369	CcSEcCtD
Riluzole—Dermatitis—Apraclonidine—glaucoma	0.000232	0.000369	CcSEcCtD
Riluzole—Headache—Apraclonidine—glaucoma	0.00023	0.000367	CcSEcCtD
Riluzole—Confusional state—Clonidine—glaucoma	0.00023	0.000365	CcSEcCtD
Riluzole—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	0.000229	0.0036	CbGpPWpGaD
Riluzole—Rhinitis—Timolol—glaucoma	0.000228	0.000364	CcSEcCtD
Riluzole—Oedema—Clonidine—glaucoma	0.000228	0.000362	CcSEcCtD
Riluzole—Tremor—Betaxolol—glaucoma	0.000228	0.000362	CcSEcCtD
Riluzole—Hallucination—Timolol—glaucoma	0.000227	0.000361	CcSEcCtD
Riluzole—Asthenia—Brimonidine—glaucoma	0.000227	0.000361	CcSEcCtD
Riluzole—Infection—Clonidine—glaucoma	0.000226	0.00036	CcSEcCtD
Riluzole—Body temperature increased—Pilocarpine—glaucoma	0.000225	0.000359	CcSEcCtD
Riluzole—Abdominal pain—Pilocarpine—glaucoma	0.000225	0.000359	CcSEcCtD
Riluzole—Ill-defined disorder—Betaxolol—glaucoma	0.000225	0.000359	CcSEcCtD
Riluzole—Diarrhoea—Acetazolamide—glaucoma	0.000225	0.000358	CcSEcCtD
Riluzole—Rash—Bimatoprost—glaucoma	0.000225	0.000358	CcSEcCtD
Riluzole—Dermatitis—Bimatoprost—glaucoma	0.000225	0.000358	CcSEcCtD
Riluzole—Oedema peripheral—Timolol—glaucoma	0.000224	0.000357	CcSEcCtD
Riluzole—Anaemia—Betaxolol—glaucoma	0.000224	0.000357	CcSEcCtD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000224	0.00352	CbGpPWpGaD
Riluzole—Shock—Clonidine—glaucoma	0.000224	0.000356	CcSEcCtD
Riluzole—Connective tissue disorder—Timolol—glaucoma	0.000224	0.000356	CcSEcCtD
Riluzole—Pruritus—Brimonidine—glaucoma	0.000223	0.000356	CcSEcCtD
Riluzole—Headache—Bimatoprost—glaucoma	0.000223	0.000356	CcSEcCtD
Riluzole—Nervous system disorder—Clonidine—glaucoma	0.000223	0.000355	CcSEcCtD
Riluzole—Thrombocytopenia—Clonidine—glaucoma	0.000223	0.000355	CcSEcCtD
Riluzole—Hypersensitivity—Dorzolamide—glaucoma	0.000222	0.000354	CcSEcCtD
Riluzole—Tachycardia—Clonidine—glaucoma	0.000222	0.000354	CcSEcCtD
Riluzole—Hypersensitivity—Travoprost—glaucoma	0.000221	0.000352	CcSEcCtD
Riluzole—Skin disorder—Clonidine—glaucoma	0.000221	0.000352	CcSEcCtD
Riluzole—Hyperhidrosis—Clonidine—glaucoma	0.00022	0.00035	CcSEcCtD
Riluzole—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000219	0.00344	CbGpPWpGaD
Riluzole—Malaise—Betaxolol—glaucoma	0.000219	0.000349	CcSEcCtD
Riluzole—Nausea—Apraclonidine—glaucoma	0.000219	0.000348	CcSEcCtD
Riluzole—Hypersensitivity—Brinzolamide—glaucoma	0.000219	0.000348	CcSEcCtD
Riluzole—Vertigo—Betaxolol—glaucoma	0.000218	0.000347	CcSEcCtD
Riluzole—Syncope—Betaxolol—glaucoma	0.000218	0.000347	CcSEcCtD
Riluzole—Dizziness—Acetazolamide—glaucoma	0.000218	0.000346	CcSEcCtD
Riluzole—Anorexia—Clonidine—glaucoma	0.000217	0.000345	CcSEcCtD
Riluzole—Asthenia—Dorzolamide—glaucoma	0.000216	0.000345	CcSEcCtD
Riluzole—Asthenia—Travoprost—glaucoma	0.000216	0.000343	CcSEcCtD
Riluzole—Palpitations—Betaxolol—glaucoma	0.000215	0.000342	CcSEcCtD
Riluzole—Pruritus—Dorzolamide—glaucoma	0.000213	0.00034	CcSEcCtD
Riluzole—Loss of consciousness—Betaxolol—glaucoma	0.000213	0.00034	CcSEcCtD
Riluzole—Eye disorder—Timolol—glaucoma	0.000213	0.000339	CcSEcCtD
Riluzole—Asthenia—Brinzolamide—glaucoma	0.000213	0.000339	CcSEcCtD
Riluzole—Hypotension—Clonidine—glaucoma	0.000213	0.000339	CcSEcCtD
Riluzole—Pruritus—Travoprost—glaucoma	0.000213	0.000338	CcSEcCtD
Riluzole—Cough—Betaxolol—glaucoma	0.000212	0.000337	CcSEcCtD
Riluzole—Nausea—Bimatoprost—glaucoma	0.000212	0.000337	CcSEcCtD
Riluzole—Cardiac disorder—Timolol—glaucoma	0.000211	0.000337	CcSEcCtD
Riluzole—Hypersensitivity—Pilocarpine—glaucoma	0.00021	0.000334	CcSEcCtD
Riluzole—Pruritus—Brinzolamide—glaucoma	0.00021	0.000334	CcSEcCtD
Riluzole—Vomiting—Acetazolamide—glaucoma	0.000209	0.000333	CcSEcCtD
Riluzole—Dizziness—Brimonidine—glaucoma	0.000209	0.000332	CcSEcCtD
Riluzole—ABCG2—Metabolism—CA5A—glaucoma	0.000208	0.00327	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NARFL—glaucoma	0.000208	0.00327	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000208	0.00326	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Clonidine—glaucoma	0.000207	0.00033	CcSEcCtD
Riluzole—Angiopathy—Timolol—glaucoma	0.000207	0.000329	CcSEcCtD
Riluzole—Chest pain—Betaxolol—glaucoma	0.000207	0.000329	CcSEcCtD
Riluzole—Myalgia—Betaxolol—glaucoma	0.000207	0.000329	CcSEcCtD
Riluzole—Arthralgia—Betaxolol—glaucoma	0.000207	0.000329	CcSEcCtD
Riluzole—Diarrhoea—Dorzolamide—glaucoma	0.000206	0.000329	CcSEcCtD
Riluzole—Headache—Acetazolamide—glaucoma	0.000206	0.000328	CcSEcCtD
Riluzole—Anxiety—Betaxolol—glaucoma	0.000206	0.000328	CcSEcCtD
Riluzole—Insomnia—Clonidine—glaucoma	0.000206	0.000328	CcSEcCtD
Riluzole—Immune system disorder—Timolol—glaucoma	0.000206	0.000328	CcSEcCtD
Riluzole—Diarrhoea—Travoprost—glaucoma	0.000206	0.000327	CcSEcCtD
Riluzole—Mediastinal disorder—Timolol—glaucoma	0.000205	0.000327	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000205	0.000327	CcSEcCtD
Riluzole—Asthenia—Pilocarpine—glaucoma	0.000205	0.000326	CcSEcCtD
Riluzole—Paraesthesia—Clonidine—glaucoma	0.000204	0.000325	CcSEcCtD
Riluzole—Discomfort—Betaxolol—glaucoma	0.000204	0.000325	CcSEcCtD
Riluzole—Arrhythmia—Timolol—glaucoma	0.000204	0.000324	CcSEcCtD
Riluzole—Dyspnoea—Clonidine—glaucoma	0.000203	0.000323	CcSEcCtD
Riluzole—Diarrhoea—Brinzolamide—glaucoma	0.000203	0.000323	CcSEcCtD
Riluzole—Somnolence—Clonidine—glaucoma	0.000202	0.000322	CcSEcCtD
Riluzole—Dry mouth—Betaxolol—glaucoma	0.000202	0.000322	CcSEcCtD
Riluzole—Pruritus—Pilocarpine—glaucoma	0.000202	0.000321	CcSEcCtD
Riluzole—Alopecia—Timolol—glaucoma	0.000201	0.000321	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—GSTT1—glaucoma	0.000201	0.00316	CbGpPWpGaD
Riluzole—Confusional state—Betaxolol—glaucoma	0.0002	0.000318	CcSEcCtD
Riluzole—Mental disorder—Timolol—glaucoma	0.0002	0.000318	CcSEcCtD
Riluzole—Dizziness—Dorzolamide—glaucoma	0.000199	0.000318	CcSEcCtD
Riluzole—Rash—Brimonidine—glaucoma	0.000199	0.000317	CcSEcCtD
Riluzole—Dermatitis—Brimonidine—glaucoma	0.000199	0.000317	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—PAX6—glaucoma	0.000199	0.00312	CbGpPWpGaD
Riluzole—Dizziness—Travoprost—glaucoma	0.000199	0.000316	CcSEcCtD
Riluzole—Malnutrition—Timolol—glaucoma	0.000198	0.000316	CcSEcCtD
Riluzole—Oedema—Betaxolol—glaucoma	0.000198	0.000315	CcSEcCtD
Riluzole—Headache—Brimonidine—glaucoma	0.000198	0.000315	CcSEcCtD
Riluzole—Decreased appetite—Clonidine—glaucoma	0.000198	0.000315	CcSEcCtD
Riluzole—Infection—Betaxolol—glaucoma	0.000197	0.000313	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000197	0.00309	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000197	0.00309	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Clonidine—glaucoma	0.000197	0.000313	CcSEcCtD
Riluzole—Fatigue—Clonidine—glaucoma	0.000196	0.000312	CcSEcCtD
Riluzole—Dizziness—Brinzolamide—glaucoma	0.000196	0.000312	CcSEcCtD
Riluzole—Nausea—Acetazolamide—glaucoma	0.000195	0.000311	CcSEcCtD
Riluzole—Diarrhoea—Pilocarpine—glaucoma	0.000195	0.00031	CcSEcCtD
Riluzole—Shock—Betaxolol—glaucoma	0.000195	0.00031	CcSEcCtD
Riluzole—Tension—Timolol—glaucoma	0.000195	0.00031	CcSEcCtD
Riluzole—Pain—Clonidine—glaucoma	0.000195	0.00031	CcSEcCtD
Riluzole—Constipation—Clonidine—glaucoma	0.000195	0.00031	CcSEcCtD
Riluzole—Nervous system disorder—Betaxolol—glaucoma	0.000194	0.000309	CcSEcCtD
Riluzole—Dysgeusia—Timolol—glaucoma	0.000194	0.000309	CcSEcCtD
Riluzole—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000194	0.00305	CbGpPWpGaD
Riluzole—Thrombocytopenia—Betaxolol—glaucoma	0.000194	0.000309	CcSEcCtD
Riluzole—Tachycardia—Betaxolol—glaucoma	0.000193	0.000308	CcSEcCtD
Riluzole—Nervousness—Timolol—glaucoma	0.000193	0.000307	CcSEcCtD
Riluzole—Skin disorder—Betaxolol—glaucoma	0.000192	0.000306	CcSEcCtD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000192	0.00302	CbGpPWpGaD
Riluzole—Vomiting—Dorzolamide—glaucoma	0.000192	0.000305	CcSEcCtD
Riluzole—Hyperhidrosis—Betaxolol—glaucoma	0.000192	0.000305	CcSEcCtD
Riluzole—Rash—Dorzolamide—glaucoma	0.00019	0.000303	CcSEcCtD
Riluzole—Dermatitis—Dorzolamide—glaucoma	0.00019	0.000302	CcSEcCtD
Riluzole—Rash—Travoprost—glaucoma	0.000189	0.000301	CcSEcCtD
Riluzole—Dermatitis—Travoprost—glaucoma	0.000189	0.000301	CcSEcCtD
Riluzole—Headache—Dorzolamide—glaucoma	0.000189	0.000301	CcSEcCtD
Riluzole—Anorexia—Betaxolol—glaucoma	0.000189	0.000301	CcSEcCtD
Riluzole—Vomiting—Brinzolamide—glaucoma	0.000189	0.0003	CcSEcCtD
Riluzole—Dizziness—Pilocarpine—glaucoma	0.000188	0.0003	CcSEcCtD
Riluzole—Headache—Travoprost—glaucoma	0.000188	0.0003	CcSEcCtD
Riluzole—Nausea—Brimonidine—glaucoma	0.000188	0.000299	CcSEcCtD
Riluzole—Feeling abnormal—Clonidine—glaucoma	0.000188	0.000299	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—MMP1—glaucoma	0.000187	0.00294	CbGpPWpGaD
Riluzole—Rash—Brinzolamide—glaucoma	0.000187	0.000298	CcSEcCtD
Riluzole—Dermatitis—Brinzolamide—glaucoma	0.000187	0.000297	CcSEcCtD
Riluzole—Gastrointestinal pain—Clonidine—glaucoma	0.000186	0.000296	CcSEcCtD
Riluzole—Headache—Brinzolamide—glaucoma	0.000186	0.000296	CcSEcCtD
Riluzole—Hypotension—Betaxolol—glaucoma	0.000185	0.000295	CcSEcCtD
Riluzole—Angioedema—Timolol—glaucoma	0.000181	0.000289	CcSEcCtD
Riluzole—Vomiting—Pilocarpine—glaucoma	0.000181	0.000288	CcSEcCtD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000181	0.00284	CbGpPWpGaD
Riluzole—Urticaria—Clonidine—glaucoma	0.000181	0.000288	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000181	0.000287	CcSEcCtD
Riluzole—Abdominal pain—Clonidine—glaucoma	0.00018	0.000286	CcSEcCtD
Riluzole—Body temperature increased—Clonidine—glaucoma	0.00018	0.000286	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—CAV1—glaucoma	0.00018	0.00282	CbGpPWpGaD
Riluzole—Rash—Pilocarpine—glaucoma	0.00018	0.000286	CcSEcCtD
Riluzole—Dermatitis—Pilocarpine—glaucoma	0.00018	0.000286	CcSEcCtD
Riluzole—Insomnia—Betaxolol—glaucoma	0.000179	0.000285	CcSEcCtD
Riluzole—Nausea—Dorzolamide—glaucoma	0.000179	0.000285	CcSEcCtD
Riluzole—Headache—Pilocarpine—glaucoma	0.000179	0.000284	CcSEcCtD
Riluzole—Nausea—Travoprost—glaucoma	0.000178	0.000284	CcSEcCtD
Riluzole—Vertigo—Timolol—glaucoma	0.000178	0.000284	CcSEcCtD
Riluzole—Paraesthesia—Betaxolol—glaucoma	0.000178	0.000283	CcSEcCtD
Riluzole—Syncope—Timolol—glaucoma	0.000178	0.000283	CcSEcCtD
Riluzole—Dyspnoea—Betaxolol—glaucoma	0.000177	0.000281	CcSEcCtD
Riluzole—Nausea—Brinzolamide—glaucoma	0.000176	0.00028	CcSEcCtD
Riluzole—Palpitations—Timolol—glaucoma	0.000175	0.000279	CcSEcCtD
Riluzole—Dyspepsia—Betaxolol—glaucoma	0.000174	0.000278	CcSEcCtD
Riluzole—Loss of consciousness—Timolol—glaucoma	0.000174	0.000278	CcSEcCtD
Riluzole—Cough—Timolol—glaucoma	0.000173	0.000276	CcSEcCtD
Riluzole—Decreased appetite—Betaxolol—glaucoma	0.000172	0.000274	CcSEcCtD
Riluzole—Hypertension—Timolol—glaucoma	0.000171	0.000273	CcSEcCtD
Riluzole—Gastrointestinal disorder—Betaxolol—glaucoma	0.000171	0.000272	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—FN1—glaucoma	0.000171	0.00269	CbGpPWpGaD
Riluzole—Fatigue—Betaxolol—glaucoma	0.000171	0.000272	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00017	0.00268	CbGpPWpGaD
Riluzole—Pain—Betaxolol—glaucoma	0.000169	0.00027	CcSEcCtD
Riluzole—Constipation—Betaxolol—glaucoma	0.000169	0.00027	CcSEcCtD
Riluzole—Nausea—Pilocarpine—glaucoma	0.000169	0.00027	CcSEcCtD
Riluzole—Chest pain—Timolol—glaucoma	0.000169	0.000269	CcSEcCtD
Riluzole—Arthralgia—Timolol—glaucoma	0.000169	0.000269	CcSEcCtD
Riluzole—Myalgia—Timolol—glaucoma	0.000169	0.000269	CcSEcCtD
Riluzole—Anxiety—Timolol—glaucoma	0.000168	0.000268	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000168	0.000267	CcSEcCtD
Riluzole—Hypersensitivity—Clonidine—glaucoma	0.000168	0.000267	CcSEcCtD
Riluzole—Discomfort—Timolol—glaucoma	0.000167	0.000266	CcSEcCtD
Riluzole—Dry mouth—Timolol—glaucoma	0.000165	0.000263	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000163	0.00257	CbGpPWpGaD
Riluzole—Asthenia—Clonidine—glaucoma	0.000163	0.00026	CcSEcCtD
Riluzole—Feeling abnormal—Betaxolol—glaucoma	0.000163	0.00026	CcSEcCtD
Riluzole—Confusional state—Timolol—glaucoma	0.000163	0.00026	CcSEcCtD
Riluzole—Oedema—Timolol—glaucoma	0.000162	0.000258	CcSEcCtD
Riluzole—Anaphylactic shock—Timolol—glaucoma	0.000162	0.000258	CcSEcCtD
Riluzole—Pruritus—Clonidine—glaucoma	0.000161	0.000256	CcSEcCtD
Riluzole—Infection—Timolol—glaucoma	0.000161	0.000256	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—CYP1B1—glaucoma	0.00016	0.00252	CbGpPWpGaD
Riluzole—Shock—Timolol—glaucoma	0.000159	0.000254	CcSEcCtD
Riluzole—Nervous system disorder—Timolol—glaucoma	0.000159	0.000253	CcSEcCtD
Riluzole—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000158	0.00248	CbGpPWpGaD
Riluzole—Urticaria—Betaxolol—glaucoma	0.000157	0.000251	CcSEcCtD
Riluzole—Skin disorder—Timolol—glaucoma	0.000157	0.00025	CcSEcCtD
Riluzole—Body temperature increased—Betaxolol—glaucoma	0.000157	0.000249	CcSEcCtD
Riluzole—Hyperhidrosis—Timolol—glaucoma	0.000157	0.000249	CcSEcCtD
Riluzole—Diarrhoea—Clonidine—glaucoma	0.000156	0.000248	CcSEcCtD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000155	0.00243	CbGpPWpGaD
Riluzole—Anorexia—Timolol—glaucoma	0.000154	0.000246	CcSEcCtD
Riluzole—Hypotension—Timolol—glaucoma	0.000151	0.000241	CcSEcCtD
Riluzole—Dizziness—Clonidine—glaucoma	0.000151	0.00024	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00015	0.00235	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000149	0.00234	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Timolol—glaucoma	0.000148	0.000235	CcSEcCtD
Riluzole—Insomnia—Timolol—glaucoma	0.000146	0.000233	CcSEcCtD
Riluzole—Hypersensitivity—Betaxolol—glaucoma	0.000146	0.000232	CcSEcCtD
Riluzole—Paraesthesia—Timolol—glaucoma	0.000145	0.000231	CcSEcCtD
Riluzole—Vomiting—Clonidine—glaucoma	0.000145	0.00023	CcSEcCtD
Riluzole—Dyspnoea—Timolol—glaucoma	0.000144	0.00023	CcSEcCtD
Riluzole—Somnolence—Timolol—glaucoma	0.000144	0.000229	CcSEcCtD
Riluzole—Rash—Clonidine—glaucoma	0.000144	0.000228	CcSEcCtD
Riluzole—Dermatitis—Clonidine—glaucoma	0.000143	0.000228	CcSEcCtD
Riluzole—Headache—Clonidine—glaucoma	0.000143	0.000227	CcSEcCtD
Riluzole—Dyspepsia—Timolol—glaucoma	0.000143	0.000227	CcSEcCtD
Riluzole—Asthenia—Betaxolol—glaucoma	0.000142	0.000226	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CA5A—glaucoma	0.000141	0.00221	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NARFL—glaucoma	0.000141	0.00221	CbGpPWpGaD
Riluzole—Decreased appetite—Timolol—glaucoma	0.000141	0.000224	CcSEcCtD
Riluzole—Pruritus—Betaxolol—glaucoma	0.00014	0.000223	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.00014	0.0022	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.00014	0.0022	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Timolol—glaucoma	0.00014	0.000222	CcSEcCtD
Riluzole—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.00014	0.00219	CbGpPWpGaD
Riluzole—Fatigue—Timolol—glaucoma	0.00014	0.000222	CcSEcCtD
Riluzole—Pain—Timolol—glaucoma	0.000138	0.00022	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—NOS3—glaucoma	0.000136	0.00213	CbGpPWpGaD
Riluzole—Diarrhoea—Betaxolol—glaucoma	0.000136	0.000216	CcSEcCtD
Riluzole—Nausea—Clonidine—glaucoma	0.000135	0.000215	CcSEcCtD
Riluzole—Feeling abnormal—Timolol—glaucoma	0.000133	0.000212	CcSEcCtD
Riluzole—Gastrointestinal pain—Timolol—glaucoma	0.000132	0.000211	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000132	0.00208	CbGpPWpGaD
Riluzole—Dizziness—Betaxolol—glaucoma	0.000131	0.000209	CcSEcCtD
Riluzole—Urticaria—Timolol—glaucoma	0.000129	0.000205	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000128	0.00201	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTM1—glaucoma	0.000128	0.00201	CbGpPWpGaD
Riluzole—Body temperature increased—Timolol—glaucoma	0.000128	0.000204	CcSEcCtD
Riluzole—Abdominal pain—Timolol—glaucoma	0.000128	0.000204	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—glaucoma	0.000127	0.002	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	0.000126	0.00198	CbGpPWpGaD
Riluzole—Vomiting—Betaxolol—glaucoma	0.000126	0.000201	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000125	0.00197	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000125	0.00197	CbGpPWpGaD
Riluzole—Rash—Betaxolol—glaucoma	0.000125	0.000199	CcSEcCtD
Riluzole—Dermatitis—Betaxolol—glaucoma	0.000125	0.000199	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000125	0.00196	CbGpPWpGaD
Riluzole—Headache—Betaxolol—glaucoma	0.000124	0.000198	CcSEcCtD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000124	0.00194	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP2—glaucoma	0.000123	0.00193	CbGpPWpGaD
Riluzole—Hypersensitivity—Timolol—glaucoma	0.000119	0.00019	CcSEcCtD
Riluzole—Nausea—Betaxolol—glaucoma	0.000118	0.000187	CcSEcCtD
Riluzole—Asthenia—Timolol—glaucoma	0.000116	0.000185	CcSEcCtD
Riluzole—Pruritus—Timolol—glaucoma	0.000115	0.000182	CcSEcCtD
Riluzole—Diarrhoea—Timolol—glaucoma	0.000111	0.000176	CcSEcCtD
Riluzole—Dizziness—Timolol—glaucoma	0.000107	0.00017	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000104	0.00164	CbGpPWpGaD
Riluzole—Vomiting—Timolol—glaucoma	0.000103	0.000164	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000102	0.0016	CbGpPWpGaD
Riluzole—Rash—Timolol—glaucoma	0.000102	0.000162	CcSEcCtD
Riluzole—Dermatitis—Timolol—glaucoma	0.000102	0.000162	CcSEcCtD
Riluzole—ABCG2—Metabolism—CA1—glaucoma	0.000102	0.0016	CbGpPWpGaD
Riluzole—Headache—Timolol—glaucoma	0.000101	0.000161	CcSEcCtD
Riluzole—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000101	0.00158	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CTSA—glaucoma	9.85e-05	0.00155	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—VEGFA—glaucoma	9.79e-05	0.00154	CbGpPWpGaD
Riluzole—Nausea—Timolol—glaucoma	9.62e-05	0.000153	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.55e-05	0.0015	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CA2—glaucoma	9.3e-05	0.00146	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP9—glaucoma	9.23e-05	0.00145	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NARFL—glaucoma	8.99e-05	0.00141	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA5A—glaucoma	8.99e-05	0.00141	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	8.93e-05	0.0014	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	8.93e-05	0.0014	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP2—glaucoma	8.76e-05	0.00138	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—glaucoma	8.29e-05	0.0013	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTM1—glaucoma	8.17e-05	0.00128	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	8.06e-05	0.00127	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—glaucoma	7.4e-05	0.00116	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CA1—glaucoma	6.89e-05	0.00108	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CTSA—glaucoma	6.67e-05	0.00105	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP9—glaucoma	6.59e-05	0.00103	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TXN—glaucoma	6.56e-05	0.00103	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CA2—glaucoma	6.3e-05	0.000989	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.16e-05	0.000967	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.16e-05	0.000967	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—VEGFA—glaucoma	5.91e-05	0.000929	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTT1—glaucoma	5.08e-05	0.000798	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—glaucoma	5.07e-05	0.000796	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TXN—glaucoma	4.44e-05	0.000697	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA1—glaucoma	4.39e-05	0.000689	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CTSA—glaucoma	4.25e-05	0.000668	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCA1—glaucoma	4.05e-05	0.000636	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP1B1—glaucoma	4.05e-05	0.000636	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.05e-05	0.000636	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA2—glaucoma	4.02e-05	0.000631	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.01e-05	0.00063	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.93e-05	0.000616	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.93e-05	0.000616	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTT1—glaucoma	3.44e-05	0.00054	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—glaucoma	3.24e-05	0.000508	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MTHFR—glaucoma	2.86e-05	0.000449	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TXN—glaucoma	2.83e-05	0.000444	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.77e-05	0.000436	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP1B1—glaucoma	2.74e-05	0.00043	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCA1—glaucoma	2.74e-05	0.00043	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOE—glaucoma	2.66e-05	0.000418	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAV1—glaucoma	2.64e-05	0.000414	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.58e-05	0.000405	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.56e-05	0.000402	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTT1—glaucoma	2.19e-05	0.000344	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—glaucoma	2.19e-05	0.000344	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NOS3—glaucoma	2e-05	0.000313	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MTHFR—glaucoma	1.94e-05	0.000304	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—glaucoma	1.83e-05	0.000287	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOE—glaucoma	1.8e-05	0.000283	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAV1—glaucoma	1.79e-05	0.000281	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.77e-05	0.000278	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCA1—glaucoma	1.75e-05	0.000274	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP1B1—glaucoma	1.75e-05	0.000274	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—glaucoma	1.4e-05	0.000219	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NOS3—glaucoma	1.35e-05	0.000212	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—glaucoma	1.24e-05	0.000194	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTHFR—glaucoma	1.24e-05	0.000194	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOE—glaucoma	1.15e-05	0.000181	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAV1—glaucoma	1.14e-05	0.000179	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NOS3—glaucoma	8.61e-06	0.000135	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—glaucoma	7.88e-06	0.000124	CbGpPWpGaD
